Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 591

1.

Clinical characteristics and long-term prognosis of elderly-onset Crohn's disease.

Song EM, Kim N, Lee SH, Chang K, Hwang SW, Park SH, Yang DH, Byeon JS, Myung SJ, Yang SK, Ye BD.

Scand J Gastroenterol. 2018 Feb 19:1-9. doi: 10.1080/00365521.2018.1437927. [Epub ahead of print]

PMID:
29457917
2.

Cryo-EM structure of the bacterial actin AlfA reveals unique assembly and ATP-binding interactions and the absence of a conserved subdomain.

Usluer GD, DiMaio F, Yang SK, Hansen JM, Polka JK, Mullins RD, Kollman JM.

Proc Natl Acad Sci U S A. 2018 Feb 13. pii: 201715836. doi: 10.1073/pnas.1715836115. [Epub ahead of print]

PMID:
29440491
3.

Prevalence of Fructose Malabsorption in Patients With Irritable Bowel Syndrome After Excluding Small Intestinal Bacterial Overgrowth.

Jung KW, Seo M, Cho YH, Park YO, Yoon SY, Lee J, Yang DH, Yoon IJ, Seo SY, Lee HJ, Park SH, Kim KJ, Ye BD, Byeon JS, Jung HY, Yang SK, Kim JH, Myung SJ.

J Neurogastroenterol Motil. 2018 Feb 13. doi: 10.5056/jnm17044. [Epub ahead of print]

4.

Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management.

Park DI, Hisamatsu T, Chen M, Ng SC, Ooi CJ, Wei SC, Banerjee R, Hilmi IN, Jeen YT, Han DS, Kim HJ, Ran Z, Wu K, Qian J, Hu PJ, Matsuoka K, Andoh A, Suzuki Y, Sugano K, Watanabe M, Hibi T, Puri AS, Yang SK.

Intest Res. 2018 Jan;16(1):17-25. doi: 10.5217/ir.2018.16.1.17. Epub 2018 Jan 18. Review.

5.

Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment.

Park DI, Hisamatsu T, Chen M, Ng SC, Ooi CJ, Wei SC, Banerjee R, Hilmi IN, Jeen YT, Han DS, Kim HJ, Ran Z, Wu K, Qian J, Hu PJ, Matsuoka K, Andoh A, Suzuki Y, Sugano K, Watanabe M, Hibi T, Puri AS, Yang SK.

Intest Res. 2018 Jan;16(1):4-16. doi: 10.5217/ir.2018.16.1.4. Epub 2018 Jan 18. Review.

6.

Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease - an International, Cross-disciplinary Consensus.

Kim AH, Roberts C, Feagan BG, Banerjee R, Bemelman W, Bodger K, Derieppe M, Dignass A, Driscoll R, Fitzpatrick R, Gaarentstroom-Lunt J, Higgins PD, Kotze PG, Meissner J, O'Connor M, Ran ZH, Siegel CA, Terry H, van Deen WK, van der Woude CJ, Weaver A, Yang SK, Sands BE, Vermeire S, Travis SP.

J Crohns Colitis. 2017 Dec 5. doi: 10.1093/ecco-jcc/jjx161. [Epub ahead of print]

PMID:
29216349
7.

Development, validation, and application of a novel tool to measure disease-related knowledge in patients with inflammatory bowel disease.

Yoon H, Yang SK, So H, Lee KE, Park SH, Jung SA, Choh JH, Shin CM, Park YS, Kim N, Lee DH.

Korean J Intern Med. 2017 Nov 29. doi: 10.3904/kjim.2017.104. [Epub ahead of print]

8.

Local recurrence and subsequent endoscopic treatment after endoscopic piecemeal mucosal resection with or without precutting in the colorectum.

Seo M, Song EM, Kim GU, Hwang SW, Park SH, Yang DH, Kim KJ, Ye BD, Myung SJ, Yang SK, Byeon JS.

Intest Res. 2017 Oct;15(4):502-510. doi: 10.5217/ir.2017.15.4.502. Epub 2017 Oct 23.

9.

Case Report of Successful Medical Management of Progressive Gastric Band Penetration-to-Perforation After Band Insertion at Bariatric Surgery: Documentation by 12 Serial EGDs During 50 months of Observation.

Aneese AM, Yang SK, Cappell MS.

Dig Dis Sci. 2018 Jan;63(1):257-263. doi: 10.1007/s10620-017-4783-8. Epub 2017 Nov 13. No abstract available.

PMID:
29134298
10.

Additivity vs Synergism: Investigation of the Additive Interaction of Cinnamon Bark Oil and Meropenem in Combinatory Therapy.

Yang SK, Yusoff K, Mai CW, Lim WM, Yap WS, Lim SE, Lai KS.

Molecules. 2017 Nov 4;22(11). pii: E1733. doi: 10.3390/molecules22111733.

11.

Risk factors for postoperative recurrence after primary bowel resection in patients with Crohn's disease.

Yang KM, Yu CS, Lee JL, Kim CW, Yoon YS, Park IJ, Lim SB, Park SH, Ye BD, Yang SK, Kim JC.

World J Gastroenterol. 2017 Oct 14;23(38):7016-7024. doi: 10.3748/wjg.v23.i38.7016.

12.

CT Enterography for Surveillance of Anastomotic Recurrence within 12 Months of Bowel Resection in Patients with Crohn's Disease: An Observational Study Using an 8-Year Registry.

Choi IY, Park SH, Park SH, Yu CS, Yoon YS, Lee JL, Ye BD, Kim AY, Yang SK.

Korean J Radiol. 2017 Nov-Dec;18(6):906-914. doi: 10.3348/kjr.2017.18.6.906. Epub 2017 Sep 21.

13.

Association of CDKN2A/CDKN2B with inflammatory bowel disease in Koreans.

Lee HS, Lee SB, Kim BM, Hong M, Jung S, Hong J, Baek J, Han B, Oh SH, Kim KM, Park SH, Yang SK, Ye BD, Song K.

J Gastroenterol Hepatol. 2017 Oct 24. doi: 10.1111/jgh.14031. [Epub ahead of print]

PMID:
29063720
14.

Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.

Lee SH, Kim MJ, Chang K, Song EM, Hwang SW, Park SH, Yang DH, Kim KJ, Byeon JS, Myung SJ, Yang SK, Ye BD.

BMC Gastroenterol. 2017 Oct 23;17(1):110. doi: 10.1186/s12876-017-0669-7.

15.

Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management.

Park DI, Hisamatsu T, Chen M, Ng SC, Ooi CJ, Wei SC, Banerjee R, Hilmi IN, Jeen YT, Han DS, Kim HJ, Ran Z, Wu K, Qian J, Hu PJ, Matsuoka K, Andoh A, Suzuki Y, Sugano K, Watanabe M, Hibi T, Puri AS, Yang SK.

J Gastroenterol Hepatol. 2018 Jan;33(1):30-36. doi: 10.1111/jgh.14018. Review.

PMID:
29024102
16.

Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment.

Park DI, Hisamatsu T, Chen M, Ng SC, Ooi CJ, Wei SC, Banerjee R, Hilmi IN, Jeen YT, Han DS, Kim HJ, Ran Z, Wu K, Qian J, Hu PJ, Matsuoka K, Andoh A, Suzuki Y, Sugano K, Watanabe M, Hibi T, Puri AS, Yang SK.

J Gastroenterol Hepatol. 2018 Jan;33(1):20-29. doi: 10.1111/jgh.14019. Review.

PMID:
29023903
17.

Temporal trends in the misdiagnosis rates between Crohn's disease and intestinal tuberculosis.

Seo H, Lee S, So H, Kim D, Kim SO, Soh JS, Bae JH, Lee SH, Hwang SW, Park SH, Yang DH, Kim KJ, Byeon JS, Myung SJ, Yang SK, Ye BD.

World J Gastroenterol. 2017 Sep 14;23(34):6306-6314. doi: 10.3748/wjg.v23.i34.6306.

18.

Role of IL-1ra and Granzyme B as biomarkers in active Crohn's disease patients.

Kim TJ, Koo JS, Kim SJ, Hong SN, Kim YS, Yang SK, Kim YH.

Biomarkers. 2018 Mar;23(2):161-166. doi: 10.1080/1354750X.2017.1387933. Epub 2017 Oct 16.

PMID:
28972805
19.

Effect of combined solifenacin and aclatonium in preventing dry mouth in patients with overactive bladder.

Park HK, Kim HG, Yang DY, Choi WS, Paick SH, Chung H, Yang SK.

Low Urin Tract Symptoms. 2017 Oct 1. doi: 10.1111/luts.12194. [Epub ahead of print]

PMID:
28967201
20.

Molecular Imaging of Colorectal Tumors by Targeting Colon Cancer Secreted Protein-2 (CCSP-2).

Kim J, Do EJ, Moinova H, Bae SM, Kang JY, Hong SM, Fink SP, Joo J, Suh YA, Jang SJ, Hwang SW, Park SH, Yang DH, Ye BD, Byeon JS, Choe J, Yang SK, Markowitz SD, Kim SY, Myung SJ.

Neoplasia. 2017 Oct;19(10):805-816. doi: 10.1016/j.neo.2017.07.003. Epub 2017 Sep 5.

Supplemental Content

Support Center